Biology:Methylprednisolone succinate
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| Trade names | Solu-Medrol, Solu-Medrone, Urbason, others |
| Other names | Methylprednisolone hemisuccinate; 6α-Methylprednisolone 21-hemisuccinate |
| AHFS/Drugs.com | Monograph |
| License data | |
| Routes of administration | Intravenous injection |
| Drug class | Corticosteroid; Glucocorticoid |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C26H34O8 |
| Molar mass | 474.550 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Methylprednisolone succinate, sold under the brand name Solu-Medrol among others, is a synthetic glucocorticoid corticosteroid and a corticosteroid ester—specifically the C21 succinate ester of methylprednisolone—which is used by intravenous administration.[2][3] Methylprednisolone succinate is provided as two different salts when used as a pharmaceutical drug: a sodium salt (methylprednisolone sodium succinate; brand name Solu-Medrol, others) and a hydrogen salt (methylprednisolone hemisuccinate or methylprednisolone hydrogen succinate; brand name Urbason).[2][3]
Methylprednisolone succinate was approved for medical use in the United States in 1959.[1]
References
- ↑ 1.0 1.1 "Solu-Medrol- methylprednisolone sodium succinate injection, powder, for solution". 17 December 2021. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7271310c-7764-4812-aa30-a5e90987c7a9.
- ↑ 2.0 2.1 The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. 14 November 2014. pp. 811–. ISBN 978-1-4757-2085-3. https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA811.
- ↑ 3.0 3.1 Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 675–. ISBN 978-3-88763-075-1. https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA675.
 |  |
